7781-26-2 Usage
Uses
Used in Pharmaceutical Industry:
5-BROMO-4,6-DICHLOROPYRIMIDIN-2-AMINE is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique functional groups allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-BROMO-4,6-DICHLOROPYRIMIDIN-2-AMINE serves as a building block for the creation of novel agrochemicals. Its incorporation into these compounds can lead to the development of more effective and targeted pest control solutions.
Used in Organic Chemistry Research:
5-BROMO-4,6-DICHLOROPYRIMIDIN-2-AMINE is utilized as a valuable chemical intermediate in organic chemistry research. Its presence in various chemical reactions can facilitate the synthesis of complex organic compounds and materials with diverse applications.
Used in Material Science:
5-BROMO-4,6-DICHLOROPYRIMIDIN-2-AMINE is employed in the development of new materials with specific properties. Its integration into material compositions can enhance their performance in various applications, such as in electronics, coatings, or advanced materials.
Overall, 5-BROMO-4,6-DICHLOROPYRIMIDIN-2-AMINE's diverse applications across different industries highlight its significance as a chemical intermediate, contributing to the advancement of pharmaceuticals, agrochemicals, organic chemistry research, and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 7781-26-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,8 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7781-26:
(6*7)+(5*7)+(4*8)+(3*1)+(2*2)+(1*6)=122
122 % 10 = 2
So 7781-26-2 is a valid CAS Registry Number.
InChI:InChI=1/C4H2BrCl2N3/c5-1-2(6)9-4(8)10-3(1)7/h(H2,8,9,10)
7781-26-2Relevant academic research and scientific papers
TRIAZOLO-PYRIMIDINE COMPOUNDS AND USES THEREOF
-
Page/Page column 90, (2020/05/07)
The present disclosure relates to novel triazolo-pyrimidine compounds targeting adenosine receptors (especially A1 and A2, particularly A2a). The present disclosure also relates to pharmaceutical compositions comprising one or more of the compounds as an active ingredient, and use of the compounds in the treatment of adenosine receptor (AR) associated diseases, for example cancer such as NSCLC, RCC, prostate cancer, and breast cancer.
4-SUBSTITUTED-2-AMINO-PYRIMIDINE DERIVATIVES
-
Page/Page column 18, (2011/01/05)
Compounds of the formula wherein R1 and R2 are as disclosed herein, are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor full or partial agonists. Also disclosed are pharmaceutical compositions, methods for using such compounds and compositions, and processes for preparing the compounds
Pyrimidines and uses thereof
-
, (2008/06/13)
The invention relates to pyrimidines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity and/or proliferation of cells such as tumor-cells.
